BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED
The company serves as the UK manufacturing and operational subsidiary of Bristol Myers Squibb, a New York-listed American multinational biopharmaceutical group focused on treatments for oncology, haematology, and cardiovascular diseases.
Get an alert when BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£376K
+637.3% vs 2023
Net assets
£186M
-15.2% vs 2023
Employees
401
-7.4% vs 2023
Profit before tax
£18M
+30.9% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £367,762,000 | £285,426,000 | -22.4% | |
| Operating profit | £18,029,000 | £16,969,000 | -5.9% | |
| Profit before tax | £14,046,000 | £18,393,000 | +30.9% | |
| Net profit | £10,887,000 | £13,393,000 | +23% | |
| Cash | £51,000 | £376,000 | +637.3% | |
| Total assets less current liabilities | £231,913,000 | £222,781,000 | -3.9% | |
| Net assets | £218,877,000 | £185,713,000 | -15.2% | |
| Equity | £218,877,000 | £185,713,000 | -15.2% | |
| Average employees | 433 | 401 | -7.4% | |
| Wages | £43,265,000 | £43,350,000 | +0.2% | |
| Directors' remuneration | £753,000 | £692,000 | -8.1% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 4.9% | 5.9% | |
| Net margin | 3.0% | 4.7% | |
| Return on capital employed | 7.8% | 7.6% | |
| Gearing (liabilities / total assets) | 39.7% | 37.3% | |
| Current ratio | 2.42x | 3.24x | |
| Interest cover | 4.53x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED 1990-10-11 → present
- TRUSHELFCO (NO. 1607) LIMITED 1990-04-02 → 1990-10-11
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“These financial statements have been prepared on the basis that the company is a going concern. Through continued cost savings, the monitoring of existing products, new product launches and the monitoring of the changes made to the business structure, the Company continues to be profitable.”
Group structure
- BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED · parent
- Celgene Limited 100%
Significant events
- “During the year, The Company has expanded the oncology portfolios with the successful launch of Opdualag (nivolumab-relatimab) and the cardiovascular porfolio with Camzyos (mavacamten).”
- “The decrease in turnover is mainly driven by the loss of exclusivity in certain brands such as Eliquis (apixaban) and Revlimid (lenalidomide).”
- “the company undertook a strategic restructuring of its workforce”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 39 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OLIVER, Guy Edward | Director | 2024-03-11 | May 1978 | New Zealander,British |
| ONG, Annie | Director | 2023-04-03 | Apr 1974 | Malaysian |
Show 39 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| COSTELLO, Simon James | Secretary | 2004-06-04 | 2006-06-01 |
| HORNBY, John Martin | Secretary | 1993-10-01 | 1997-06-30 |
| HUGHES, Alison Sian | Secretary | 2001-05-31 | 2004-06-04 |
| JACKSON, Alastair John William | Secretary | 1998-07-01 | 2001-05-31 |
| LAWSON, James | Secretary | — | 1993-09-30 |
| SINGARAYER, Diella Natasha | Secretary | 2006-06-01 | 2008-04-07 |
| CITCO MANAGEMENT (UK) LIMITED | Corporate Secretary | 2024-01-01 | 2025-06-15 |
| PETERSHILL SECRETARIES LIMITED | Corporate Secretary | 2019-01-11 | 2024-01-01 |
| SLC REGISTRARS LIMITED | Corporate Secretary | 2008-04-07 | 2019-01-11 |
| ALLAKER, Stephen | Director | 2004-06-04 | 2015-03-12 |
| BROWN, Clement Mccune | Director | — | 1991-09-27 |
| BURNS, Daniel Richard | Director | 1995-07-17 | 1996-12-31 |
| CAZALA, Beatrice Jeanne Therese | Director | 2002-08-27 | 2004-07-23 |
| CELENTANO, John Elie | Director | 2000-03-01 | 2002-08-27 |
| COOKE, John Scott | Director | 2021-07-20 | 2023-11-30 |
| DASH, Clive Harry, Doctor | Director | — | 1994-05-12 |
| DE LASA, Jose Maria | Director | — | 1994-12-02 |
| DIARRA, Amadou | Director | 2010-12-01 | 2014-05-01 |
| DOLLARD, Francis Michael | Director | 1992-07-30 | 2001-12-19 |
| DUCHESNE, Frederic | Director | 2008-08-01 | 2010-12-01 |
| GRAMES, Conan Paul | Director | 1995-08-01 | 1999-04-01 |
| GROSJEAN, Bertrand Pierre Marie | Director | 2015-03-12 | 2019-03-15 |
| HANNAY, David Robert | Director | — | 1994-01-31 |
| HICKEY, Benjamin Joseph | Director | 2016-08-01 | 2018-09-03 |
| HOCH, Lynelle Baumgardner | Director | 2019-04-01 | 2021-07-20 |
| HOOPER, Anthony Campbell | Director | 1997-05-01 | 2000-03-01 |
| JACKSON, Alastair John William | Director | — | 2001-05-31 |
| KASA, Pamela Dorothy | Director | — | 1994-07-18 |
| KELLY, Linda Mary | Director | 1992-05-01 | 1995-04-28 |
| LAWSON, James | Director | — | 1993-09-30 |
| LOBERG, Michael Dewey, Dr | Director | 1992-04-01 | 1993-12-31 |
| MAGUIN EP WALSH, Veronique, Michelle, Monique | Director | 2018-09-03 | 2019-04-01 |
| MERCIER, Johanna | Director | 2014-04-15 | 2016-08-01 |
| MORGAN, Gareth Huw | Director | 2003-04-29 | 2006-06-01 |
| PASQUALONE, Frank Carlo | Director | 2007-02-09 | 2008-08-01 |
| STARK, Kenneth | Director | 2001-12-19 | 2004-11-25 |
| VARGAS QUINTAS CAMPOS, Teresa Maria | Director | 2019-03-15 | 2022-10-03 |
| VEITCH, David William | Director | 2004-10-01 | 2007-06-01 |
| WRIGHT, Phillip James | Director | — | 1992-12-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bristol-Myers Squibb Holdings 2002 Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 202 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-15 | AA | accounts | Accounts with accounts type full | |
| 2025-06-30 | AD02 | address | Change sail address company with old address new address | |
| 2025-06-30 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-04-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-03 | AA | accounts | Accounts with accounts type full | |
| 2024-04-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-03-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-25 | AD02 | address | Change sail address company with old address new address | |
| 2024-01-25 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-01-25 | AP04 | officers | Appoint corporate secretary company with name date | |
| 2023-11-30 | TM01 | officers | Termination director company with name termination date | |
| 2023-06-16 | AA | accounts | Accounts with accounts type full | |
| 2023-04-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-04 | AP01 | officers | Appoint person director company with name date | |
| 2022-11-08 | TM01 | officers | Termination director company with name termination date | |
| 2022-09-23 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-09-23 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-07-14 | CH04 | officers | Change corporate secretary company with change date | |
| 2022-06-16 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.